Virpax Pharmaceuticals (VRPX) had the highest return between July 26, 2021 and August 30, 2021 by a US stock, returning 394.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Virpax Pharmaceuticals (VRPX) | 7/26/2021 - 8/30/2021 | 394.29% |
Greenidge Generation (GREE) | 7/26/2021 - 8/30/2021 | 361.22% |
ATIF (ATIF) | 7/26/2021 - 8/30/2021 | 307.23% |
DatChat Inc Series A Warrant (DATSW) | 7/26/2021 - 8/30/2021 | 250.68% |
Fulcrum Therapeutics (FULC) | 7/26/2021 - 8/30/2021 | 247.22% |
Regencell Bioscience (RGC) | 7/26/2021 - 8/30/2021 | 219.82% |
Flora Growth (FLGC) | 7/26/2021 - 8/30/2021 | 203.9% |
Mega Matrix (MPU) | 7/26/2021 - 8/30/2021 | 191.89% |
BeyondSpring (BYSI) | 7/26/2021 - 8/30/2021 | 183.56% |
Bit Digital (BTBT) | 7/26/2021 - 8/30/2021 | 162.41% |
Pixelworks (PXLW) | 7/26/2021 - 8/30/2021 | 119.01% |
XORTX Therapeutics (XRTX) | 7/26/2021 - 8/30/2021 | 117.4% |
Sphere 3D (ANY) | 7/26/2021 - 8/30/2021 | 114.77% |
Taskus (TASK) | 7/26/2021 - 8/30/2021 | 94.22% |
RenovoRx (RNXT) | 7/26/2021 - 8/30/2021 | 94.18% |
Dynavax Technologies (DVAX) | 7/26/2021 - 8/30/2021 | 91.43% |
Next Technology (NXTT) | 7/26/2021 - 8/30/2021 | 90% |
Nuvalent (NUVL) | 7/26/2021 - 8/30/2021 | 88.84% |
BriaCell Therapeutics (BCTXW) | 7/26/2021 - 8/30/2021 | 87.5% |
DatChat (DATS) | 7/26/2021 - 8/30/2021 | 86.58% |
Zenvia (ZENV) | 7/26/2021 - 8/30/2021 | 86.27% |
Upstart Holdings (UPST) | 7/26/2021 - 8/30/2021 | 84.64% |
Monday (MNDY) | 7/26/2021 - 8/30/2021 | 83.38% |
Dyadic International (DYAI) | 7/26/2021 - 8/30/2021 | 80.67% |
Valneva SE ADR (VALN) | 7/26/2021 - 8/30/2021 | 80.17% |
